These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7581910)

  • 1. Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
    Kajita M; Niwa T; Fujisaki M; Ueki M; Niimura K; Sato M; Egami K; Naoi M; Yoshida M; Nagatsu T
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):345-51. PubMed ID: 7581910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
    Biochem Biophys Res Commun; 1991 Jun; 177(2):603-9. PubMed ID: 2049084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
    Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous synthesis of N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of N-methylisoquinolinium ion, in the brains of primates with parkinsonism after systemic administration of 1,2,3,4-tetrahydroisoquinoline.
    Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Yoshida M; Kawachi M; Naoi M; Nagatsu T
    J Chromatogr; 1990 Nov; 533():145-51. PubMed ID: 2127934
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry.
    Niwa T; Takeda N; Sasaoka T; Kaneda N; Hashizume Y; Yoshizumi H; Tatematsu A; Nagatsu T
    J Chromatogr; 1989 Jul; 491(2):397-403. PubMed ID: 2808624
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in parkinsonian brain.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
    Adv Neurol; 1993; 60():234-7. PubMed ID: 8420140
    [No Abstract]   [Full Text] [Related]  

  • 7. Presence of N-methyldopamine in parkinsonian and normal human brains.
    Kajita M; Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Watanabe K; Nagatsu T
    J Chromatogr; 1993 Mar; 613(1):1-8. PubMed ID: 8458887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
    Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring.
    Igarashi K; Sugiyama Y; Kasuya F; Saiki K; Yamakawa T; Ohata S
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):53-8. PubMed ID: 10491989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain.
    Kohno M; Ohta S; Hirobe M
    Biochem Biophys Res Commun; 1986 Oct; 140(1):448-54. PubMed ID: 3778459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
    Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
    J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
    Makino Y; Ohta S; Tachikawa O; Hirobe M
    Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
    Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
    J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxins: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydroisoquinoline and 1-methyl-6,7-dihydroxy-tetrahydroisoquinoline as substrates for FAD-containing monooxygenase of porcine liver microsomes.
    Wu RF; Miura S; Ichikawa Y
    Biochem Pharmacol; 1992 Nov; 44(10):2079-81. PubMed ID: 1449525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo.
    Okuda K; Kotake Y; Ohta S
    Biol Pharm Bull; 2006 Jul; 29(7):1401-3. PubMed ID: 16819177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous synthesis of N-methylnorsalsolinol in rat brain during in vivo microdialysis with epinine.
    Kajita M; Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Watanabe K; Naoi M; Nagatsu T
    J Chromatogr B Biomed Appl; 1994 Apr; 654(2):263-9. PubMed ID: 8044287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction.
    Yamakawa T; Ohta S
    Neurosci Lett; 1999 Jan; 259(3):157-60. PubMed ID: 10025582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry in Parkinson's disease.
    Niwa T
    Clin Chim Acta; 1995; 241-242():223-50. PubMed ID: 8612340
    [No Abstract]   [Full Text] [Related]  

  • 20. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
    Kotake Y; Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1995 Dec; 65(6):2633-8. PubMed ID: 7595560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.